Correlation Between Champions Oncology and Rallybio Corp

Can any of the company-specific risk be diversified away by investing in both Champions Oncology and Rallybio Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Champions Oncology and Rallybio Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Champions Oncology and Rallybio Corp, you can compare the effects of market volatilities on Champions Oncology and Rallybio Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Champions Oncology with a short position of Rallybio Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Champions Oncology and Rallybio Corp.

Diversification Opportunities for Champions Oncology and Rallybio Corp

0.57

Correlation Coefficient

Champions Oncology  Rallybio Corp

Very weak diversification

The 3 months correlation between Champions and Rallybio is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Champions Oncology and Rallybio Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rallybio Corp and Champions Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Champions Oncology are associated (or correlated) with Rallybio Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rallybio Corp has no effect on the direction of Champions Oncology i.e., Champions Oncology and Rallybio Corp go up and down completely randomly.

Pair Corralation between Champions Oncology and Rallybio Corp

Given the investment horizon of 90 days Champions Oncology is expected to generate 2.28 times more return on investment than Rallybio Corp. However, Champions Oncology is 2.28 times more volatile than Rallybio Corp. It trades about 0.06 of its potential returns per unit of risk. Rallybio Corp is currently generating about -0.01 per unit of risk. If you would invest  428.00  in Champions Oncology on July 20, 2024 and sell it today you would earn a total of  16.00  from holding Champions Oncology or generate 3.74% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Champions Oncology  vs.  Rallybio Corp

Champions Oncology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Champions Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest unfluctuating performance, the Stock's fundamental drivers remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.

Rallybio Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Rallybio Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in November 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Champions Oncology and Rallybio Corp

The main advantage of trading using opposite Champions Oncology and Rallybio Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Champions Oncology position performs unexpectedly, Rallybio Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rallybio Corp will offset losses from the drop in Rallybio Corp's long position.

The idea behind Champions Oncology and Rallybio Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..